BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Pfeffer MA, Shah AM, Borlaug BA. Heart Failure With Preserved Ejection Fraction In Perspective. Circ Res. 2019;124:1598-1617. [PMID: 31120821 DOI: 10.1161/circresaha.119.313572] [Cited by in Crossref: 165] [Cited by in F6Publishing: 74] [Article Influence: 82.5] [Reference Citation Analysis]
Number Citing Articles
1 Vaz-salvador P, Adão R, Vasconcelos I, Leite-moreira AF, Brás-silva C. Heart Failure with Preserved Ejection Fraction: a Pharmacotherapeutic Update. Cardiovasc Drugs Ther. [DOI: 10.1007/s10557-021-07306-8] [Reference Citation Analysis]
2 Cuijpers I, Carai P, Mendes-Ferreira P, Simmonds SJ, Mulder P, Miranda-Silva D, De Giorgio D, Pokreisz P, Heymans S, Jones EAV. The effect of different anaesthetics on echocardiographic evaluation of diastolic dysfunction in a heart failure with preserved ejection fraction model. Sci Rep 2020;10:15701. [PMID: 32973263 DOI: 10.1038/s41598-020-72924-5] [Reference Citation Analysis]
3 Imamura T, Gonoi W, Hori M, Ueno Y, Narang N, Onoda H, Tanaka S, Nakamura M, Kataoka N, Ushijima R, Sobajima M, Fukuda N, Ueno H, Kinugawa K. Validation of Noninvasive Remote Dielectric Sensing System to Quantify Lung Fluid Levels. J Clin Med 2021;11:164. [PMID: 35011905 DOI: 10.3390/jcm11010164] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 6.0] [Reference Citation Analysis]
4 Adams SJ, Haddad H. Artificial Intelligence to Diagnose Heart Failure Based on Chest X-Rays and Potential Clinical Implications. Can J Cardiol 2021;37:1153-5. [PMID: 33667617 DOI: 10.1016/j.cjca.2021.02.016] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
5 Chen Z, Lin Q, Li J, Wang X, Ju J, Xu H, Shi D. Estimated Glomerular Filtration Rate Is Associated With an Increased Risk of Death in Heart Failure Patients With Preserved Ejection Fraction. Front Cardiovasc Med 2021;8:643358. [PMID: 33981733 DOI: 10.3389/fcvm.2021.643358] [Reference Citation Analysis]
6 Borlaug BA, Nelson MD. Real-Time Cardiac Magnetic Resonance Imaging: A New Spin on the Evaluation of HFpEF. Circulation 2021;143:1499-501. [PMID: 33844580 DOI: 10.1161/CIRCULATIONAHA.120.053026] [Reference Citation Analysis]
7 Takabayashi K, Terasaki Y, Okuda M, Nakajima O, Koito H, Kitamura T, Kitaguchi S, Nohara R. The clinical characteristics and outcomes of heart failure patient with chronic obstructive pulmonary disease from the Japanese community-based registry. Heart Vessels 2021;36:223-34. [PMID: 32770265 DOI: 10.1007/s00380-020-01675-0] [Reference Citation Analysis]
8 Marra AM, Bencivenga L, D'Assante R, Rengo G, Cittadini A. Heart failure with preserved ejection fraction: Squaring the circle between comorbidities and cardiovascular abnormalities. Eur J Intern Med 2022:S0953-6205(22)00018-8. [PMID: 35033395 DOI: 10.1016/j.ejim.2022.01.019] [Reference Citation Analysis]
9 Ajmal M, Ajmal A, Huang L, Zeng L. The Potential Therapeutic Role of Celastrol in Patients With Heart Failure With Preserved Ejection Fraction. Front Cardiovasc Med 2021;8:725602. [PMID: 34490381 DOI: 10.3389/fcvm.2021.725602] [Reference Citation Analysis]
10 Costa BM, Mengal V, Brasil GA, Peluso AA, Treebak JT, Endlich PW, de Almeida SA, de Abreu GR. Ellagic Acid Prevents Myocardial Infarction-induced Left Ventricular Diastolic Dysfunction in Ovariectomized Rats. J Nutr Biochem 2022;:108990. [PMID: 35331902 DOI: 10.1016/j.jnutbio.2022.108990] [Reference Citation Analysis]
11 Bjerring AW, Fosså SD, Haugnes HS, Nome R, Stokke TM, Haugaa KH, Kiserud CE, Edvardsen T, Sarvari SI. The cardiac impact of cisplatin-based chemotherapy in survivors of testicular cancer: a 30-year follow-up. Eur Heart J Cardiovasc Imaging 2021;22:443-50. [PMID: 33152065 DOI: 10.1093/ehjci/jeaa289] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
12 Sweeney M, Corden B, Cook SA. Targeting cardiac fibrosis in heart failure with preserved ejection fraction: mirage or miracle? EMBO Mol Med 2020;12:e10865. [PMID: 32955172 DOI: 10.15252/emmm.201910865] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 6.0] [Reference Citation Analysis]
13 Ling HS, Chung BK, Chua PF, Gan KX, Ho WL, Ong EYL, Kueh CHS, Chin YP, Fong AYY. Acute decompensated heart failure in a non cardiology tertiary referral centre, Sarawak General Hospital (SGH-HF). BMC Cardiovasc Disord 2020;20:511. [PMID: 33287705 DOI: 10.1186/s12872-020-01793-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
14 Rieger AC, Bagno LL, Salerno A, Florea V, Rodriguez J, Rosado M, Turner D, Dulce RA, Takeuchi LM, Kanashiro-Takeuchi RM, Buchwald P, Wanschel ACBA, Balkan W, Schulman IH, Schally AV, Hare JM. Growth hormone-releasing hormone agonists ameliorate chronic kidney disease-induced heart failure with preserved ejection fraction. Proc Natl Acad Sci U S A 2021;118:e2019835118. [PMID: 33468654 DOI: 10.1073/pnas.2019835118] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
15 Gori M, Marini M, De Maria R, Gonzini L, Gorini M, Cassaniti L, Benvenuto M, Municinò A, Navazio A, Ammirati E, Leonardi G, Pagnoni N, Montagna L, Catalano M, Midi P, Floresta AM, Pulignano G, Maggioni AP, Tavazzi L, Iacoviello M; Italian Network on Heart Failure (IN-HF) Investigators. Age-related changes in clinical characteristics and outcomes of chronic heart failure outpatients in a cardiology setting. A report from the Italian Network on Heart Failure. Int J Cardiol 2022;346:36-44. [PMID: 34793855 DOI: 10.1016/j.ijcard.2021.11.014] [Reference Citation Analysis]
16 Li H, Hastings MH, Rhee J, Trager LE, Roh JD, Rosenzweig A. Targeting Age-Related Pathways in Heart Failure. Circ Res 2020;126:533-51. [PMID: 32078451 DOI: 10.1161/CIRCRESAHA.119.315889] [Cited by in Crossref: 25] [Cited by in F6Publishing: 14] [Article Influence: 12.5] [Reference Citation Analysis]
17 Reddy YNV, Obokata M, Jones AD, Lewis GD, Shah SJ, Abouezzedine OF, Fudim M, Alhanti B, Stevenson LW, Redfield MM, Borlaug BA. Characterization of the Progression From Ambulatory to Hospitalized Heart Failure With Preserved Ejection Fraction. J Card Fail 2020;26:919-28. [PMID: 32827644 DOI: 10.1016/j.cardfail.2020.08.008] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
18 Krebber MM, van Dijk CGM, Vernooij RWM, Brandt MM, Emter CA, Rau CD, Fledderus JO, Duncker DJ, Verhaar MC, Cheng C, Joles JA. Matrix Metalloproteinases and Tissue Inhibitors of Metalloproteinases in Extracellular Matrix Remodeling during Left Ventricular Diastolic Dysfunction and Heart Failure with Preserved Ejection Fraction: A Systematic Review and Meta-Analysis. Int J Mol Sci 2020;21:E6742. [PMID: 32937927 DOI: 10.3390/ijms21186742] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
19 Díez-Villanueva P, Jiménez-Méndez C, Alfonso F. Heart failure in the elderly. J Geriatr Cardiol 2021;18:219-32. [PMID: 33907552 DOI: 10.11909/j.issn.1671-5411.2021.03.009] [Reference Citation Analysis]
20 Díez-López C, Tajes Orduña M, Enjuanes Grau C, Moliner Borja P, González-Costello J, García-Romero E, Francesch Manzano J, Yun Viladomat S, Jiménez-Marrero S, Ramos-Polo R, Ras Jiménez MDM, Comín-Colet J. Blood Differential Gene Expression in Patients with Chronic Heart Failure and Systemic Iron Deficiency: Pathways Involved in Pathophysiology and Impact on Clinical Outcomes. J Clin Med 2021;10:4937. [PMID: 34768457 DOI: 10.3390/jcm10214937] [Reference Citation Analysis]
21 Wang CH, Han S, Tong F, Li Y, Li ZC, Sun ZJ. Risk prediction model of in-hospital mortality in heart failure with preserved ejection fraction and mid-range ejection fraction: a retrospective cohort study. Biomark Med 2021;15:1223-32. [PMID: 34498488 DOI: 10.2217/bmm-2021-0025] [Reference Citation Analysis]
22 Lindsey ML, Deleon-Pennell KY, Bradshaw AD, Larue RAC, Anderson DR, Thiele GM, Baicu CF, Jones JA, Menick DR, Zile MR, Spinale FG. Focusing Heart Failure Research on Myocardial Fibrosis to Prioritize Translation. J Card Fail 2020;26:876-84. [PMID: 32446948 DOI: 10.1016/j.cardfail.2020.05.009] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
23 Jiang J, Yang B, Sun Y, Jin J, Zhao Z, Chen S. Diagnostic Value of Serum Concentration of Galectin-3 in Patients With Heart Failure With Preserved Ejection Fraction. Front Cardiovasc Med 2022;8:829151. [DOI: 10.3389/fcvm.2021.829151] [Reference Citation Analysis]
24 Henning RJ. Diagnosis and treatment of heart failure with preserved left ventricular ejection fraction. World J Cardiol 2020; 12(1): 7-25 [PMID: 31984124 DOI: 10.4330/wjc.v12.i1.7] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 5.0] [Reference Citation Analysis]
25 Dzhioeva O, Belyavskiy E. Diagnosis and Management of Patients with Heart Failure with Preserved Ejection Fraction (HFpEF): Current Perspectives and Recommendations. Ther Clin Risk Manag 2020;16:769-85. [PMID: 32904123 DOI: 10.2147/TCRM.S207117] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
26 Kintscher U, Foryst-Ludwig A, Haemmerle G, Zechner R. The Role of Adipose Triglyceride Lipase and Cytosolic Lipolysis in Cardiac Function and Heart Failure. Cell Rep Med 2020;1:100001. [PMID: 33205054 DOI: 10.1016/j.xcrm.2020.100001] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
27 Alshehri M, Wilcox C. Diuretic Resistance Treated with Low-Dose Hydralazine: A Case Report and Review of the Literature. Case Rep Nephrol Dial 2021;11:254-60. [PMID: 34595213 DOI: 10.1159/000515387] [Reference Citation Analysis]
28 Fermoyle CC, Stewart GM, Borlaug BA, Johnson BD. Pulmonary Vascular Pressures and Gas Exchange Response to Exercise in Heart Failure With Preserved Ejection Fraction. J Card Fail 2020;26:1011-5. [PMID: 32750488 DOI: 10.1016/j.cardfail.2020.07.009] [Reference Citation Analysis]
29 Huang CH, Kor CT, Lian IB, Chang CC. Menopausal symptoms and risk of heart failure: a retrospective analysis from Taiwan National Health Insurance Database. ESC Heart Fail 2021;8:3295-307. [PMID: 34151548 DOI: 10.1002/ehf2.13480] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
30 Kelley RC, Betancourt L, Noriega AM, Brinson SC, Curbello-Bermudez N, Hahn D, Kumar RA, Balazic E, Muscato DR, Ryan TE, van der Pijl RJ, Shen S, Ottenheijm CAC, Ferreira LF. Skeletal myopathy in a rat model of postmenopausal heart failure with preserved ejection fraction. J Appl Physiol (1985) 2021. [PMID: 34792407 DOI: 10.1152/japplphysiol.00170.2021] [Reference Citation Analysis]
31 Kaur H, Premkumar M. Diagnosis and Management of Cirrhotic Cardiomyopathy. Journal of Clinical and Experimental Hepatology 2022;12:186-99. [DOI: 10.1016/j.jceh.2021.08.016] [Reference Citation Analysis]
32 Vaishnav J, Sharma K. A Stepwise Guide to the Diagnosis and Treatment of Heart Failure with Preserved Ejection Fraction. J Card Fail 2021:S1071-9164(21)00525-X. [PMID: 34968656 DOI: 10.1016/j.cardfail.2021.12.013] [Reference Citation Analysis]
33 German CA, Brubaker PH, Nelson MB, Fanning J, Ye F, Kitzman DW. Relationships Between Objectively Measured Physical Activity, Exercise Capacity, and Quality of Life in Older Patients With Obese Heart Failure and Preserved Ejection Fraction. J Card Fail 2021;27:635-41. [PMID: 34088379 DOI: 10.1016/j.cardfail.2020.12.025] [Reference Citation Analysis]
34 Graziani F, Lillo R, Crea F. Rationale for the Use of Pirfenidone in Heart Failure With Preserved Ejection Fraction. Front Cardiovasc Med 2021;8:678530. [PMID: 33969025 DOI: 10.3389/fcvm.2021.678530] [Reference Citation Analysis]
35 Vinter N, Cordsen P, Lip GY, Benjamin EJ, Johnsen SP, Frost L, Trinquart L. Life-Years Lost After Newly Diagnosed Atrial Fibrillation in Patients with Heart Failure. CLEP 2022;Volume 14:711-20. [DOI: 10.2147/clep.s365706] [Reference Citation Analysis]
36 Kaye DM, Wolsk E, Nanayakkara S, Mariani J, Hassager C, Gustafsson F, Moller JE, Sunagawa K, Burkhoff D. Comprehensive Physiological Modeling Provides Novel Insights Into Heart Failure With Preserved Ejection Fraction Physiology. J Am Heart Assoc 2021;10:e021584. [PMID: 34569288 DOI: 10.1161/JAHA.121.021584] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
37 Gordon JS, Blazoski CM, Wood CT, Zuber C, Massey HT, Throckmorton A, Tchantchaleishvili V. Mechanical and interventional support for heart failure with preserved ejection fraction: A review. Artif Organs 2022. [PMID: 35579447 DOI: 10.1111/aor.14275] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
38 Shim CY. Heart Failure with Preserved Ejection Fraction: the Major Unmet Need in Cardiology. Korean Circ J 2020;50:1051-61. [PMID: 33150751 DOI: 10.4070/kcj.2020.0338] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
39 Zhang X, Li T, Cheng HJ, Wang H, Ferrario CM, Groban L, Cheng CP. Chronic GPR30 agonist therapy causes restoration of normal cardiac functional performance in a male mouse model of progressive heart failure: Insights into cellular mechanisms. Life Sci 2021;285:119955. [PMID: 34520767 DOI: 10.1016/j.lfs.2021.119955] [Reference Citation Analysis]
40 Clark KAA, Velazquez EJ. Heart Failure With Preserved Ejection Fraction: Time for a Reset. JAMA 2020;324:1506-8. [PMID: 33079136 DOI: 10.1001/jama.2020.15566] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
41 Reddy YN, Borlaug BA. Hypertension and heart failure: insights from exercise stress testing. Eur J Heart Fail 2020;22:469-71. [DOI: 10.1002/ejhf.1760] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
42 Scrutinio D, Guida P, Ruggieri R, Passantino A. Prognostic value of functional capacity after transitional rehabilitation in older patients hospitalized for heart failure. J Am Geriatr Soc 2022. [PMID: 35266550 DOI: 10.1111/jgs.17736] [Reference Citation Analysis]
43 Mohammadi E, Nasiraei-Moghaddam A, Uecker M. Real-time radial tagging for quantification of left ventricular torsion. Magn Reson Med 2022. [PMID: 35081262 DOI: 10.1002/mrm.29169] [Reference Citation Analysis]
44 Chen S, Zhou Y, Wu X, Shi S, Wu H, Li P, Khalaf OI. The Value of Echocardiography Combined with NT-pro BNP Level in Assessment and Prognosis of Diastolic Heart Failure. Computational and Mathematical Methods in Medicine 2022;2022:1-8. [DOI: 10.1155/2022/2102496] [Reference Citation Analysis]
45 Selvaraj S, Myhre PL, Vaduganathan M, Claggett BL, Matsushita K, Kitzman DW, Borlaug BA, Shah AM, Solomon SD. Application of Diagnostic Algorithms for Heart Failure With Preserved Ejection Fraction to the Community. JACC Heart Fail 2020;8:640-53. [PMID: 32535127 DOI: 10.1016/j.jchf.2020.03.013] [Cited by in Crossref: 20] [Cited by in F6Publishing: 14] [Article Influence: 10.0] [Reference Citation Analysis]
46 Kaye DM, Byrne M, Mariani J, Nanayakkara S, Burkhoff D. Identification of physiologic treatment targets with favourable haemodynamic consequences in heart failure with preserved ejection fraction. ESC Heart Fail 2020. [PMID: 32902205 DOI: 10.1002/ehf2.12908] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
47 Jung YH, Ren X, Suffredini G, Dodd-O JM, Gao WD. Right ventricular diastolic dysfunction and failure: a review. Heart Fail Rev 2021. [PMID: 34013436 DOI: 10.1007/s10741-021-10123-8] [Reference Citation Analysis]
48 Ali U, Ahmad T, Khan J, Khan MI, Khan H, Javed B. Comparison of Efficacy of Ivabradine With Traditional Therapy in Patients With Left Ventricular Dysfunction. Cureus 2021;13:e19192. [PMID: 34873532 DOI: 10.7759/cureus.19192] [Reference Citation Analysis]
49 Rethy L, Borlaug BA, Redfield MM, Oh JK, Shah SJ, Patel RB. Application of Guideline-Based Echocardiographic Assessment of Left Atrial Pressure to Heart Failure with Preserved Ejection Fraction. J Am Soc Echocardiogr 2021;34:455-64. [PMID: 33359021 DOI: 10.1016/j.echo.2020.12.008] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
50 Toledo C, Ortolani D, Ortiz FC, Marcus NJ, Del Rio R. Potential Role of the Retrotrapezoid Nucleus in Mediating Cardio-Respiratory Dysfunction in Heart Failure With Preserved Ejection Fraction. Front Physiol 2022;13:863963. [DOI: 10.3389/fphys.2022.863963] [Reference Citation Analysis]
51 Haring B, Hunt RP, Manson JE, LaMonte MJ, Klein L, Allison MA, Wild RA, Wallace RB, Shadyab AH, Breathett K, Eaton C, Wassertheil-Smoller S, Shimbo D. Blood Pressure Variability and Heart Failure Hospitalization: Results From the Women's Health Initiative. Am J Prev Med 2022:S0749-3797(22)00159-3. [PMID: 35525685 DOI: 10.1016/j.amepre.2022.03.007] [Reference Citation Analysis]
52 Boutagy NE, Singh AK, Sessa WC. Targeting the vasculature in cardiometabolic disease. J Clin Invest 2022;132:e148556. [PMID: 35289308 DOI: 10.1172/JCI148556] [Reference Citation Analysis]
53 Maforo NG, Magrath P, Moulin K, Shao J, Kim GH, Prosper A, Renella P, Wu HH, Halnon N, Ennis DB. T1-Mapping and extracellular volume estimates in pediatric subjects with Duchenne muscular dystrophy and healthy controls at 3T. J Cardiovasc Magn Reson 2020;22:85. [PMID: 33302967 DOI: 10.1186/s12968-020-00687-z] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
54 Tan W, Li X, Zheng S, Li X, Zhang X, Pyle WG, Chen H, Wu J, Sun H, Zou Y, Backx PH, Yang FH. A Porcine Model of Heart Failure With Preserved Ejection Fraction Induced by Chronic Pressure Overload Characterized by Cardiac Fibrosis and Remodeling. Front Cardiovasc Med 2021;8:677727. [PMID: 34150870 DOI: 10.3389/fcvm.2021.677727] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
55 Nguyen NT, Tran DT, Le An P, Van Hoang S, Nguyen HA, Chau HN. Clinical Phenotypes and Age-Related Differences in Presentation, Treatment, and Outcome of Heart Failure with Preserved Ejection Fraction: A Vietnamese Multicenter Research. Cardiol Res Pract 2021;2021:4587678. [PMID: 33628487 DOI: 10.1155/2021/4587678] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
56 Temporelli PL, Arbelo E, Laroche C, Blomström-Lundqvist C, Kirchhof P, Lip GYH, Boriani G, Nakou E, Maggioni AP, Tavazzi L; ESC-EHRA EORP Atrial Fibrillation Ablation Long-Term Registry Investigators. Atrial fibrillation ablation in heart failure: Findings from the ESC-EHRA EORP Atrial Fibrillation Ablation long-term (AFA LT) registry. Int J Cardiol 2022;346:19-26. [PMID: 34774883 DOI: 10.1016/j.ijcard.2021.11.010] [Reference Citation Analysis]
57 Chen X, Lin H, Xiong W, Pan J, Huang S, Xu S, He S, Lei M, Chang ACY, Zhang H. p53-Dependent Mitochondrial Compensation in Heart Failure With Preserved Ejection Fraction. J Am Heart Assoc 2022;:e024582. [PMID: 35656994 DOI: 10.1161/JAHA.121.024582] [Reference Citation Analysis]
58 Fukuta H, Hagiwara H, Kamiya T. Sodium-glucose cotransporter 2 inhibitors in heart failure with preserved ejection fraction: A protocol for meta-analysis. Medicine (Baltimore) 2021;100:e28448. [PMID: 34941199 DOI: 10.1097/MD.0000000000028448] [Reference Citation Analysis]
59 Zhang L, Chen J, Yan L, He Q, Xie H, Chen M. Resveratrol Ameliorates Cardiac Remodeling in a Murine Model of Heart Failure With Preserved Ejection Fraction. Front Pharmacol 2021;12:646240. [PMID: 34177571 DOI: 10.3389/fphar.2021.646240] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
60 Zittermann A, Trummer C, Theiler-Schwetz V, Lerchbaum E, März W, Pilz S. Vitamin D and Cardiovascular Disease: An Updated Narrative Review. Int J Mol Sci 2021;22:2896. [PMID: 33809311 DOI: 10.3390/ijms22062896] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
61 Rossitto G, Mary S, McAllister C, Neves KB, Haddow L, Rocchiccioli JP, Lang NN, Murphy CL, Touyz RM, Petrie MC, Delles C. Reduced Lymphatic Reserve in Heart Failure With Preserved Ejection Fraction. J Am Coll Cardiol 2020;76:2817-29. [PMID: 33303070 DOI: 10.1016/j.jacc.2020.10.022] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 9.0] [Reference Citation Analysis]
62 Ge J. Coding proposal on phenotyping heart failure with preserved ejection fraction: A practical tool for facilitating etiology-oriented therapy. Cardiol J 2020;27:97-8. [PMID: 32103486 DOI: 10.5603/CJ.2020.0023] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
63 Croteau D, Qin F, Chambers JM, Kallick E, Luptak I, Panagia M, Pimentel DR, Siwik DA, Colucci WS. Differential Effects of Sacubitril/Valsartan on Diastolic Function in Mice With Obesity-Related Metabolic Heart Disease. JACC Basic Transl Sci 2020;5:916-27. [PMID: 33015414 DOI: 10.1016/j.jacbts.2020.07.006] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
64 Giles L, Freeman C, Field P, Sörstadius E, Kartman B. Humanistic burden and economic impact of heart failure – a systematic review of the literature. F1000Res 2019;8:859. [DOI: 10.12688/f1000research.19365.2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
65 Severino P, D'Amato A, Prosperi S, Fanisio F, Birtolo LI, Costi B, Netti L, Chimenti C, Lavalle C, Maestrini V, Mancone M, Fedele F. Myocardial Tissue Characterization in Heart Failure with Preserved Ejection Fraction: From Histopathology and Cardiac Magnetic Resonance Findings to Therapeutic Targets. Int J Mol Sci 2021;22:7650. [PMID: 34299270 DOI: 10.3390/ijms22147650] [Reference Citation Analysis]
66 Groban L, Tran QK, Ferrario CM, Sun X, Cheng CP, Kitzman DW, Wang H, Lindsey SH. Female Heart Health: Is GPER the Missing Link? Front Endocrinol (Lausanne) 2019;10:919. [PMID: 31993020 DOI: 10.3389/fendo.2019.00919] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 6.5] [Reference Citation Analysis]
67 Lam CSP, Wood R, Vaduganathan M, Bueno H, Chin A, Luporini Saraiva G, Sörstadius E, Tritton T, Thomas J, Qin L. Contemporary economic burden in a real-world heart failure population with Commercial and Medicare supplemental plans. Clin Cardiol 2021;44:646-55. [PMID: 33704817 DOI: 10.1002/clc.23585] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
68 Packer DL, Piccini JP, Monahan KH, Al-Khalidi HR, Silverstein AP, Noseworthy PA, Poole JE, Bahnson TD, Lee KL, Mark DB; CABANA Investigators. Ablation Versus Drug Therapy for Atrial Fibrillation in Heart Failure: Results From the CABANA Trial. Circulation 2021;143:1377-90. [PMID: 33554614 DOI: 10.1161/CIRCULATIONAHA.120.050991] [Cited by in Crossref: 16] [Cited by in F6Publishing: 4] [Article Influence: 16.0] [Reference Citation Analysis]
69 Methawasin M, Strom J, Borkowski T, Hourani Z, Runyan R, Smith JE 3rd, Granzier H. Phosphodiesterase 9a Inhibition in Mouse Models of Diastolic Dysfunction. Circ Heart Fail 2020;13:e006609. [PMID: 32418479 DOI: 10.1161/CIRCHEARTFAILURE.119.006609] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 4.5] [Reference Citation Analysis]
70 Triska J, Tamargo J, Bozkurt B, Elkayam U, Taylor A, Birnbaum Y. An Updated Review on the Role of Non-dihydropyridine Calcium Channel Blockers and Beta-blockers in Atrial Fibrillation and Acute Decompensated Heart Failure: Evidence and Gaps. Cardiovasc Drugs Ther 2022. [PMID: 35357604 DOI: 10.1007/s10557-022-07334-y] [Reference Citation Analysis]
71 Keshavarz-Bahaghighat H, Darwesh AM, Sosnowski DK, Seubert JM. Mitochondrial Dysfunction and Inflammaging in Heart Failure: Novel Roles of CYP-Derived Epoxylipids. Cells 2020;9:E1565. [PMID: 32604981 DOI: 10.3390/cells9071565] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
72 Adekunle AO, Adzika GK, Mprah R, Ndzie Noah ML, Adu-Amankwaah J, Rizvi R, Akhter N, Sun H. Predominance of Heart Failure With Preserved Ejection Fraction in Postmenopausal Women: Intra- and Extra-Cardiomyocyte Maladaptive Alterations Scaffolded by Estrogen Deficiency. Front Cell Dev Biol 2021;9:685996. [PMID: 34660569 DOI: 10.3389/fcell.2021.685996] [Reference Citation Analysis]
73 Mooney L, Goodyear CS, Chandra T, Kirschner K, Copland M, Petrie MC, Lang NN. Clonal haematopoiesis of indeterminate potential: intersections between inflammation, vascular disease and heart failure. Clin Sci (Lond) 2021;135:991-1007. [PMID: 33861346 DOI: 10.1042/CS20200306] [Reference Citation Analysis]
74 Kirkman DL, Bohmke N, Billingsley HE, Carbone S. Sarcopenic Obesity in Heart Failure With Preserved Ejection Fraction. Front Endocrinol (Lausanne) 2020;11:558271. [PMID: 33117276 DOI: 10.3389/fendo.2020.558271] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
75 Sax DR, Rana JS, Mark DG, Huang J, Collins SP, Liu D, Storrow AB, Reed ME; KP CREST Network. Outcomes among acute heart failure emergency department patients by preserved vs. reduced ejection fraction. ESC Heart Fail 2021;8:2889-98. [PMID: 33978311 DOI: 10.1002/ehf2.13364] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
76 Finet JE, Van Iterson EH, Wilson Tang WH. Invasive Hemodynamic and Metabolic Evaluation of HFpEF. Curr Treat Options Cardiovasc Med 2021;23:32. [PMID: 34177247 DOI: 10.1007/s11936-021-00904-7] [Reference Citation Analysis]
77 Frljak S, Poglajen G, Vrtovec B. Cell Therapy in Heart Failure with Preserved Ejection Fraction. Card Fail Rev 2022;8:e08. [DOI: 10.15420/cfr.2021.21] [Reference Citation Analysis]
78 Del Torto A, Guaricci AI, Pomarico F, Guglielmo M, Fusini L, Monitillo F, Santoro D, Vannini M, Rossi A, Muscogiuri G, Baggiano A, Pontone G. Advances in Multimodality Cardiovascular Imaging in the Diagnosis of Heart Failure With Preserved Ejection Fraction. Front Cardiovasc Med 2022;9:758975. [DOI: 10.3389/fcvm.2022.758975] [Reference Citation Analysis]
79 Pancheva R, Yovev S, Kolev V, Stoimenov B. Do patients with heart failure and preserved, mid-range or reduced ejection fraction have different outcomes? Cor Vasa 2020;62:567-73. [DOI: 10.33678/cor.2020.089] [Reference Citation Analysis]
80 B Patel R, Somerville C, Gong FF, C Peters A, J Shah S, B Chicos A, Kim S, P Knight B, Lin A, Verma N, S Passman R. Association of the H2FPEF Risk Score with Recurrence of Atrial Fibrillation Following Pulmonary Vein Isolation. J Atr Fibrillation 2020;12:2295. [PMID: 33024491 DOI: 10.4022/jafib.2295] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
81 Hanna A, Frangogiannis NG. Inflammatory Cytokines and Chemokines as Therapeutic Targets in Heart Failure. Cardiovasc Drugs Ther 2020;34:849-63. [PMID: 32902739 DOI: 10.1007/s10557-020-07071-0] [Cited by in Crossref: 9] [Cited by in F6Publishing: 12] [Article Influence: 4.5] [Reference Citation Analysis]
82 Lopes RD, Alexander KP, Stevens SR, Reynolds HR, Stone GW, Piña IL, Rockhold FW, Elghamaz A, Lopez-Sendon JL, Farsky PS, Chernyavskiy AM, Diaz A, Phaneuf D, De Belder MA, Ma YT, Guzman LA, Khouri M, Sionis A, Hausenloy DJ, Doerr R, Selvanayagam JB, Maggioni AP, Hochman JS, Maron DJ. Initial Invasive Versus Conservative Management of Stable Ischemic Heart Disease in Patients With a History of Heart Failure or Left Ventricular Dysfunction: Insights From the ISCHEMIA Trial. Circulation 2020;142:1725-35. [PMID: 32862662 DOI: 10.1161/CIRCULATIONAHA.120.050304] [Cited by in Crossref: 18] [Cited by in F6Publishing: 6] [Article Influence: 9.0] [Reference Citation Analysis]
83 Nguyen TD, Schulze PC. Lipid in the midst of metabolic remodeling - Therapeutic implications for the failing heart. Adv Drug Deliv Rev 2020;159:120-32. [PMID: 32791076 DOI: 10.1016/j.addr.2020.08.004] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
84 Grabowski K, Herlan L, Witten A, Qadri F, Eisenreich A, Lindner D, Schädlich M, Schulz A, Subrova J, Mhatre KN, Primessnig U, Plehm R, van Linthout S, Escher F, Bader M, Stoll M, Westermann D, Heinzel FR, Kreutz R. Cpxm2 as a novel candidate for cardiac hypertrophy and failure in hypertension. Hypertens Res 2021. [PMID: 34916661 DOI: 10.1038/s41440-021-00826-8] [Reference Citation Analysis]
85 Eckhardt CM, Balte PP, Barr RG, Bertoni AG, Bhatt SP, Cuttica M, Cassano PA, Chaves P, Couper D, Jacobs DR, Kalhan R, Kronmal R, Lange L, Loehr L, London SJ, O'Connor GT, Rosamond W, Sanders J, Schwartz JE, Shah A, Shah SJ, Smith L, White W, Yende S, Oelsner EC. Lung function impairment and risk of incident heart failure: the NHLBI Pooled Cohorts Study. Eur Heart J 2022:ehac205. [PMID: 35467708 DOI: 10.1093/eurheartj/ehac205] [Reference Citation Analysis]
86 Palau P, Seller J, Domínguez E, Gómez I, Ramón JM, Sastre C, de la Espriella R, Santas E, Miñana G, Chorro FJ, González-Juanatey JR, Núñez J. Beta-blockers withdrawal in patients with heart failure with preserved ejection fraction and chronotropic incompetence: Effect on functional capacity rationale and study design of a prospective, randomized, controlled trial (The Preserve-HR trial). Clin Cardiol 2020;43:423-9. [PMID: 32073676 DOI: 10.1002/clc.23345] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
87 Turkoglu EI, Kircicegi Cicekdag EC. Heart failure with preserved ejection fraction, atrial fibrillation, and increased NT‑proBNP levels : An emergent clinical dilemma. Herz 2021;46:191-7. [PMID: 32997152 DOI: 10.1007/s00059-020-04981-5] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
88 Lai P, Nikolaev VO, De Jong KA. Understanding the Role of SERCA2a Microdomain Remodeling in Heart Failure Induced by Obesity and Type 2 Diabetes. JCDD 2022;9:163. [DOI: 10.3390/jcdd9050163] [Reference Citation Analysis]
89 Pfeffer MA, Shah AM, Borlaug BA. Response by Pfeffer et al to Letter Regarding Article, "Heart Failure With Preserved Ejection Fraction in Perspective". Circ Res 2019;125:e26. [PMID: 31518210 DOI: 10.1161/CIRCRESAHA.119.315591] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
90 Sorrentino A, Bagwan N, Linscheid N, Poulsen PC, Kahnert K, Thomsen MB, Delmar M, Lundby A. Beta-blocker/ACE inhibitor therapy differentially impacts the steady state signaling landscape of failing and non-failing hearts. Sci Rep 2022;12. [DOI: 10.1038/s41598-022-08534-0] [Reference Citation Analysis]
91 Schiattarella GG, Altamirano F, Kim SY, Tong D, Ferdous A, Piristine H, Dasgupta S, Wang X, French KM, Villalobos E, Spurgin SB, Waldman M, Jiang N, May HI, Hill TM, Luo Y, Yoo H, Zaha VG, Lavandero S, Gillette TG, Hill JA. Xbp1s-FoxO1 axis governs lipid accumulation and contractile performance in heart failure with preserved ejection fraction. Nat Commun 2021;12:1684. [PMID: 33727534 DOI: 10.1038/s41467-021-21931-9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
92 Lejeune S, Roy C, Slimani A, Pasquet A, Vancraeynest D, Beauloye C, Vanoverschelde JL, Gerber BL, Pouleur AC. Heart failure with preserved ejection fraction in Belgium: characteristics and outcome of a real-life cohort. Acta Cardiol 2021;76:697-706. [PMID: 32677871 DOI: 10.1080/00015385.2020.1770460] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
93 Shao S, Zhang Y, Gong M, Yang Q, Yuan M, Yuan M, Suo Y, Wang X, Li Y, Bao Q, Li G. Ivabradine Ameliorates Cardiac Function in Heart Failure with Preserved and Reduced Ejection Fraction via Upregulation of miR-133a. Oxid Med Cell Longev 2021;2021:1257283. [PMID: 34630844 DOI: 10.1155/2021/1257283] [Reference Citation Analysis]
94 de Castro Brás LE, Schibalski RS, Ilatovskaya DV, O'meara CC, Deleon-pennell KY. Editorial: Role of Molecular Modulators in Combatting Cardiac Injury and Disease: Prevention, Repair and Regeneration. Front Cardiovasc Med 2022;9:861442. [DOI: 10.3389/fcvm.2022.861442] [Reference Citation Analysis]
95 Eisner DA, Caldwell JL, Trafford AW, Hutchings DC. The Control of Diastolic Calcium in the Heart: Basic Mechanisms and Functional Implications. Circ Res 2020;126:395-412. [PMID: 31999537 DOI: 10.1161/CIRCRESAHA.119.315891] [Cited by in Crossref: 30] [Cited by in F6Publishing: 18] [Article Influence: 15.0] [Reference Citation Analysis]
96 Parajuli DR, Shakib S, Eng-Frost J, McKinnon RA, Caughey GE, Whitehead D. Evaluation of the prescribing practice of guideline-directed medical therapy among ambulatory chronic heart failure patients. BMC Cardiovasc Disord 2021;21:104. [PMID: 33602125 DOI: 10.1186/s12872-021-01868-z] [Reference Citation Analysis]
97 Fathi A, Vickneson K, Singh JS. SGLT2-inhibitors; more than just glycosuria and diuresis. Heart Fail Rev 2021;26:623-42. [PMID: 33274396 DOI: 10.1007/s10741-020-10038-w] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
98 Bode D, Wen Y, Hegemann N, Primessnig U, Parwani A, Boldt LH, M Pieske B, R Heinzel F, Hohendanner F. Oxidative Stress and Inflammatory Modulation of Ca2+ Handling in Metabolic HFpEF-Related Left Atrial Cardiomyopathy. Antioxidants (Basel) 2020;9:E860. [PMID: 32937823 DOI: 10.3390/antiox9090860] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
99 Rocca A, Heeswijk RBV, Richiardi J, Meyer P, Hullin R. The Cardiomyocyte in Heart Failure with Preserved Ejection Fraction—Victim of Its Environment? Cells 2022;11:867. [DOI: 10.3390/cells11050867] [Reference Citation Analysis]
100 Liu L, Li Y, Chen Q. The Emerging Role of FUNDC1-Mediated Mitophagy in Cardiovascular Diseases. Front Physiol 2021;12:807654. [PMID: 34975548 DOI: 10.3389/fphys.2021.807654] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
101 Pandey A, Vaduganathan M, Arora S, Qamar A, Mentz RJ, Shah SJ, Chang PP, Russell SD, Rosamond WD, Caughey MC. Temporal Trends in Prevalence and Prognostic Implications of Comorbidities Among Patients With Acute Decompensated Heart Failure: The ARIC Study Community Surveillance. Circulation 2020;142:230-43. [PMID: 32486833 DOI: 10.1161/CIRCULATIONAHA.120.047019] [Cited by in Crossref: 20] [Cited by in F6Publishing: 8] [Article Influence: 10.0] [Reference Citation Analysis]
102 Fukuta H. Effects of Exercise Training on Cardiac Function in Heart Failure with Preserved Ejection Fraction. Card Fail Rev 2020;6:e27. [PMID: 33133641 DOI: 10.15420/cfr.2020.17] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
103 Abd Alla J, Jamous YF, Quitterer U. Stearoyl-CoA Desaturase (SCD) Induces Cardiac Dysfunction with Cardiac Lipid Overload and Angiotensin II AT1 Receptor Protein Up-Regulation. Int J Mol Sci 2021;22:9883. [PMID: 34576047 DOI: 10.3390/ijms22189883] [Reference Citation Analysis]
104 Pacheco C, Wei J, Shufelt C, C Hitzeman T, Cook-Wiens G, Pepine CJ, Handberg E, Anderson RD, Petersen J, Hong T, M Shaw R, Bairey Merz CN. Association of coronary microvascular dysfunction and cardiac bridge integrator 1, a cardiomyocyte dysfunction biomarker. Clin Cardiol 2021;44:1586-93. [PMID: 34528718 DOI: 10.1002/clc.23726] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
105 Pandey A, Shah SJ, Butler J, Kellogg DL Jr, Lewis GD, Forman DE, Mentz RJ, Borlaug BA, Simon MA, Chirinos JA, Fielding RA, Volpi E, Molina AJA, Haykowsky MJ, Sam F, Goodpaster BH, Bertoni AG, Justice JN, White JP, Ding J, Hummel SL, LeBrasseur NK, Taffet GE, Pipinos II, Kitzman D. Exercise Intolerance in Older Adults With Heart Failure With Preserved Ejection Fraction: JACC State-of-the-Art Review. J Am Coll Cardiol 2021;78:1166-87. [PMID: 34503685 DOI: 10.1016/j.jacc.2021.07.014] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
106 Shi Y, Dong G, Liu J, Shuang X, Liu C, Yang C, Qing W, Qiao W. Clinical Implications of Plasma Galectin-3 in Heart Failure With Preserved Ejection Fraction: A Meta-Analysis. Front Cardiovasc Med 2022;9:854501. [DOI: 10.3389/fcvm.2022.854501] [Reference Citation Analysis]
107 Loai S, Zhou YQ, Vollett KDW, Cheng HM. Skeletal Muscle Microvascular Dysfunction Manifests Early in Diabetic Cardiomyopathy. Front Cardiovasc Med 2021;8:715400. [PMID: 34355034 DOI: 10.3389/fcvm.2021.715400] [Reference Citation Analysis]
108 Huston JH, Shah SJ. Understanding the Pathobiology of Pulmonary Hypertension Due to Left Heart Disease. Circ Res 2022;130:1382-403. [PMID: 35482841 DOI: 10.1161/CIRCRESAHA.122.319967] [Reference Citation Analysis]
109 Mo R, Yu LT, Tan HQ, Wang Y, Yang YM, Liang Y, Zhu J. A new scoring system for predicting short-term outcomes in Chinese patients with critically-ill acute decompensated heart failure. BMC Cardiovasc Disord 2021;21:228. [PMID: 33947350 DOI: 10.1186/s12872-021-02041-2] [Reference Citation Analysis]
110 Maltês S, Cunha GJL, Rocha BML, Guerreiro R, Duarte J, Morais R, Henriques C, Rodrigues C, Araújo I, Fonseca C. Sleep-disordered breathing patterns in hospitalized patients with acute heart failure across the entire spectrum of ejection fraction. Sleep Breath 2021. [PMID: 34671911 DOI: 10.1007/s11325-021-02511-z] [Reference Citation Analysis]
111 Samuel TJ, Wei J, Sharif B, Tamarappoo BK, Pattisapu V, Maughan J, Cipher DJ, Suppogu N, Aldiwani H, Thomson LEJ, Shufelt C, Berman DS, Li D, Bairey Merz CN, Nelson MD. Diastolic dysfunction in women with ischemia and no obstructive coronary artery disease: Mechanistic insight from magnetic resonance imaging. Int J Cardiol 2021;331:1-7. [PMID: 33545261 DOI: 10.1016/j.ijcard.2021.01.064] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
112 Groenewegen A, Zwartkruis VW, Cekic B, de Boer RA, Rienstra M, Hoes AW, Rutten FH, Hollander M. Incidence of atrial fibrillation, ischaemic heart disease and heart failure in patients with diabetes. Cardiovasc Diabetol 2021;20:123. [PMID: 34134731 DOI: 10.1186/s12933-021-01313-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
113 Barnes A, Campbell C, Weiss R, Kahwash R. Cardiac Contractility Modulation in Heart Failure: Mechanisms and Clinical Evidence. Curr Treat Options Cardio Med 2020;22. [DOI: 10.1007/s11936-020-00852-8] [Reference Citation Analysis]
114 Fyrdahl A, Ramos JG, Eriksson MJ, Caidahl K, Ugander M, Sigfridsson A. Sector-wise golden-angle phase contrast with high temporal resolution for evaluation of left ventricular diastolic dysfunction. Magn Reson Med 2020;83:1310-21. [PMID: 31631403 DOI: 10.1002/mrm.28018] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
115 Groenewegen A, Rutten FH, Mosterd A, Hoes AW. Epidemiology of heart failure. Eur J Heart Fail 2020;22:1342-56. [PMID: 32483830 DOI: 10.1002/ejhf.1858] [Cited by in Crossref: 74] [Cited by in F6Publishing: 55] [Article Influence: 37.0] [Reference Citation Analysis]
116 Aronow WS, Lloji A, Sreenivasan J, Novograd J, Pan S, Lanier GM. Heart failure with preserved ejection fraction: key stumbling blocks for experimental drugs in clinical trials. Expert Opin Investig Drugs 2022. [PMID: 35443138 DOI: 10.1080/13543784.2022.2069009] [Reference Citation Analysis]
117 Barsukov AV, Seidova AY, Shcherbakova KA, Black MS, Korovin AE, Churilov LP, Tovpeko DV. Systemic Action of Inflammatory Mediators in Patients with Essential Hypertension and Diastolic Chronic Heart Failure: A Clinical Pathophysiological Study. Pathophysiology 2020;27:30-43. [PMID: 35366254 DOI: 10.3390/pathophysiology27010005] [Reference Citation Analysis]
118 Fayssoil A, De Carnavalet MCC, Mansencal N, Lofaso F, Davido B. Cardiopulmonary Pathophysiological Aspects in the Context of COVID-19 and Obesity. SN Compr Clin Med 2021;:1-10. [PMID: 34151188 DOI: 10.1007/s42399-021-00995-0] [Reference Citation Analysis]
119 Rosalia L, Ozturk C, Shoar S, Fan Y, Malone G, Cheema FH, Conway C, Byrne RA, Duffy GP, Malone A, Roche ET, Hameed A. Device-Based Solutions to Improve Cardiac Physiology and Hemodynamics in Heart Failure With Preserved Ejection Fraction. JACC Basic Transl Sci 2021;6:772-95. [PMID: 34754993 DOI: 10.1016/j.jacbts.2021.06.002] [Reference Citation Analysis]
120 Griffin JM, Borlaug BA, Komtebedde J, Litwin SE, Shah SJ, Kaye DM, Hoendermis E, Hasenfuß G, Gustafsson F, Wolsk E, Uriel N, Burkhoff D. Impact of Interatrial Shunts on Invasive Hemodynamics and Exercise Tolerance in Patients With Heart Failure. J Am Heart Assoc 2020;9:e016760. [PMID: 32809903 DOI: 10.1161/JAHA.120.016760] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
121 Moriyama H, Endo J, Ikura H, Kitakata H, Momoi M, Shinya Y, Ko S, Ichihara G, Hiraide T, Shirakawa K, Anzai A, Katsumata Y, Sano M. Qualitative and Quantitative Effects of Fatty Acids Involved in Heart Diseases. Metabolites 2022;12:210. [DOI: 10.3390/metabo12030210] [Reference Citation Analysis]
122 Andrade DC, Díaz-Jara E, Toledo C, Schwarz KG, Pereyra KV, Díaz HS, Marcus NJ, Ortiz FC, Ríos-Gallardo AP, Ortolani D, Del Rio R. Exercise intolerance in volume overload heart failure is associated with low carotid body mediated chemoreflex drive. Sci Rep 2021;11:14458. [PMID: 34262072 DOI: 10.1038/s41598-021-93791-8] [Reference Citation Analysis]
123 Cappetta D, De Angelis A, Flamini S, Cozzolino A, Bereshchenko O, Ronchetti S, Cianflone E, Gagliardi A, Ricci E, Rafaniello C, Rossi F, Riccardi C, Berrino L, Bruscoli S, Urbanek K. Deficit of glucocorticoid-induced leucine zipper amplifies angiotensin-induced cardiomyocyte hypertrophy and diastolic dysfunction. J Cell Mol Med 2021;25:217-28. [PMID: 33247627 DOI: 10.1111/jcmm.15913] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
124 Tourki B, Halade GV. Heart Failure Syndrome With Preserved Ejection Fraction Is a Metabolic Cluster of Non-resolving Inflammation in Obesity. Front Cardiovasc Med 2021;8:695952. [PMID: 34409075 DOI: 10.3389/fcvm.2021.695952] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
125 Kanwar MK, Tedford RJ, Thenappan T, De Marco T, Park M, McLaughlin V. Elevated Pulmonary Pressure Noted on Echocardiogram: A Simplified Approach to Next Steps. J Am Heart Assoc 2021;10:e017684. [PMID: 33719491 DOI: 10.1161/JAHA.120.017684] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
126 Obradovic S, Dzudovic B, Subotic B, Matijasevic J, Mladenovic Z, Bokan A, Trobok J, Pekovic S, Salinger-Martinovic S, Jovanovic L, Kos L, Kovacevic-Preradovic T, Nikolic M, Miloradovic V, Kovacevic-Kuzmanovic A, Zec N, Markovic-Nikolic N, Srdanovic I, Gluvic Z, Kafedzic S, Pancevacki S, Neskovic A, Konstantinides S. Predictive value of heart failure with reduced versus preserved ejection fraction for outcome in pulmonary embolism. ESC Heart Fail 2020. [PMID: 32936530 DOI: 10.1002/ehf2.13015] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
127 Futami S, Ishikawa J, Maeda T, Kawano M, Sakurayama C, Harada K. Factors contributing to energy loss in left ventricle during diastolic and systolic phases in elderly patients. Echocardiography 2021;38:72-80. [PMID: 33220089 DOI: 10.1111/echo.14930] [Reference Citation Analysis]
128 Leavitt MA. Guideline-Directed Cardiac Devices for Patients with Heart Failure. Am J Nurs 2022;Published Ahead of Print. [PMID: 35551123 DOI: 10.1097/01.NAJ.0000832724.08294.fe] [Reference Citation Analysis]
129 Bernardo RJ, Haddad F, Couture EJ, Hansmann G, de Jesus Perez VA, Denault AY, de Man FS, Amsallem M. Mechanics of right ventricular dysfunction in pulmonary arterial hypertension and heart failure with preserved ejection fraction. Cardiovasc Diagn Ther 2020;10:1580-603. [PMID: 33224775 DOI: 10.21037/cdt-20-479] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
130 Tavazzi L, Maggioni AP, Rapezzi C, Ferrari R. Heart failure and catheter ablation of atrial fibrillation: Navigating the difficult waters of heart failure phenotypes. Eur J Intern Med 2022:S0953-6205(22)00086-3. [PMID: 35241349 DOI: 10.1016/j.ejim.2022.02.021] [Reference Citation Analysis]
131 Cui X, Thunström E, Dahlström U, Zhou J, Ge J, Fu M. Trends in cause-specific readmissions in heart failure with preserved vs. reduced and mid-range ejection fraction. ESC Heart Fail 2020;7:2894-903. [PMID: 32729678 DOI: 10.1002/ehf2.12899] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
132 Adamska-Wełnicka A, Wełnicki M, Mamcarz A, Gellert R. Chronic Kidney Disease and Heart Failure-Everyday Diagnostic Challenges. Diagnostics (Basel) 2021;11:2164. [PMID: 34829511 DOI: 10.3390/diagnostics11112164] [Reference Citation Analysis]
133 Nikolova AP, Hong T, Shaw RM. Letter by Nikolova et al Regarding Article, "Heart Failure With Preserved Ejection Fraction in Perspective". Circ Res 2019;125:e24-5. [PMID: 31518204 DOI: 10.1161/CIRCRESAHA.119.315583] [Reference Citation Analysis]
134 Pan B, Hu D, Sun H, Lv T, Xu W, Tian J. Pediatric Diastolic Heart Failure: Clinical Features Description of 421 Cases. Front Pediatr 2022;10:846408. [DOI: 10.3389/fped.2022.846408] [Reference Citation Analysis]
135 Saleem TH, Algowhary M, Kamel FEM, El-Mahdy RI. Plasma amino acid metabolomic pattern in heart failure patients with either preserved or reduced ejection fraction: The relation to established risk variables and prognosis. Biomed Chromatogr 2021;35:e5012. [PMID: 33119901 DOI: 10.1002/bmc.5012] [Reference Citation Analysis]
136 Li H, Qu Y, Metze P, Sommerfeld F, Just S, Abaei A, Rasche V. Quantification of Biventricular Myocardial Strain Using CMR Feature Tracking: Reproducibility in Small Animals. Biomed Res Int 2021;2021:8492705. [PMID: 33553431 DOI: 10.1155/2021/8492705] [Reference Citation Analysis]
137 Miyagi C, Fukamachi K, Kuban BD, Gao S, Miyamoto T, Flick CR, Polakowski AR, Horvath DJ, Starling RC, Karimov JH. Left Atrial Circulatory Assistance in Simulated Diastolic Heart Failure Model: First in Vitro and in Vivo. J Card Fail 2022:S1071-9164(21)00493-0. [PMID: 35027316 DOI: 10.1016/j.cardfail.2021.11.024] [Reference Citation Analysis]
138 Harris KM, Jacoby DL, Lampert R, Soucier RJ, Burg MM. Psychological stress in heart failure: a potentially actionable disease modifier. Heart Fail Rev 2021;26:561-75. [PMID: 33215323 DOI: 10.1007/s10741-020-10056-8] [Reference Citation Analysis]
139 Tian Y, Yang J, Lan M, Zou T. Construction and analysis of a joint diagnosis model of random forest and artificial neural network for heart failure. Aging (Albany NY) 2020;12:26221-35. [PMID: 33401250 DOI: 10.18632/aging.202405] [Reference Citation Analysis]
140 Kim MN, Park SM. Heart failure with preserved ejection fraction: insights from recent clinical researches. Korean J Intern Med 2020;35:514-34. [PMID: 32392659 DOI: 10.3904/kjim.2020.104] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]